Table 1 LGR5 expression and clinicopathological characteristics in PD-AC
From: LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma
Factors | LGR5 expression | |||
|---|---|---|---|---|
n | High (n = 17) | Low (n = 24) | P-value | |
Age | 0.0472 | |||
> 74 years | 19 | 11 | 8 | |
≤ 74 years | 22 | 6 | 16 | |
Sex | 0.0498 | |||
Male | 24 | 13 | 11 | |
Female | 17 | 4 | 13 | |
EBV | 0.0764 | |||
Positive | 4 | 0 | 4 | |
Negative | 37 | 17 | 20 | |
Vascular invasion | 0.0764 | |||
Present | 37 | 17 | 20 | |
Absent | 4 | 0 | 4 | |
TIL | 0.283 | |||
High | 25 | 9 | 16 | |
Low | 16 | 8 | 8 | |
MSI | 0.2176 | |||
Present | 19 | 10 | 9 | |
Absent | 21 | 7 | 14 | |
Differentiated-type | 0.2921 | |||
Solid-type 1 | 8 | 2 | 6 | |
Non-solid-type 2 | 33 | 15 | 18 | |
TNM stage | 0.9382 | |||
II | 19 | 8 | 11 | |
III | 22 | 9 | 13 | |